Revenue, 2025

USD 10.78 Billion

Forecast, 2035

USD 26.09 Billion

CAGR, 2026-2035

9.24%

Report Coverage

Global

Outpatient & Home Infusion Services Market Trends for 2026

The global outpatient & home infusion services market size was estimated at USD 10.78 billion in 2025 and is predicted to increase from USD 11.78 billion in 2026 to approximately USD 26.09 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035. The growing chronic disease burden globally is increasing the use of outpatient & home infusion services. Growing shift towards home-based care, expanding specialist therapies, technological advancements, investments, and new product launches are also enhancing the market growth.

Key Takeaways

• Outpatient & home infusion services sector pushed the market to USD 11.78 billion by 2026.
• Long-term projections show USD 26.09 billion valuation by 2035.
• Growth is expected at a steady CAGR of 9.24% in between 2026 to 2035.
• North America held the major revenue share of 47% in the global outpatient & home infusion services market in 2025.
• Asia Pacific held 16% share of the market in 2025 and is expected to grow at the fastest CAGR of 9.50% during the forecast period.
• By service type, the home infusion therapy segment held a dominant revenue share of 58% of the market in 2025.
• By service type, the immunoglobulin therapy sub-segment held 10% of market share in 2025 and is expected to grow at the fastest CAGR of 12% during the forecast period
• By disease type, the cancer segment held a dominant revenue share of 40% of the market in 2025.
• By disease type, the rheumatoid arthritis sub-segment held 10% of market share in 2025 and is expected to grow at the fastest CAGR of 12.50% during the forecast period.
• By product type, the IV infusion sets segment held a dominant revenue share of 30% of the market in 2025.
• By product type, the others segment held 10% of market share in 2025 and is expected to grow at the fastest CAGR of 9.10% during the forecast period.
• By end-user, the outpatient centers segment held a dominant position in the outpatient & home infusion services market in 2025.
• By end-user, the homecare providers segment is expected to show the fastest growth during the forecast period.

What are the Outpatient & Home Infusion Services?

The outpatient & home infusion services market is driven by a shift towards decentralized care to enhance patient comfort. The outpatient & home infusion services refer to the healthcare services offering intravenous or injectable solutions to the patient outside the hospital settings. They provide a wide range of therapies, driving their use for cancer treatment, infection treatment, nutritional support, hydration therapy, immune therapy support, and pain management.

Why is the Use of AI Increasing in the Market?

The use of AI in the outpatient & home infusion services market is increasing due to its data analysis, predictive analytics, and telehealth integration. It helps in tracking the disease complications, risk of adverse reactions, and therapy outcome, where it also helps in the development of smart infusion devices, personalized treatment plans, and medication management. AI also helps in workflow optimization, processing of patient datasets, appointment scheduling, and clinical decision support.

What are the Major Trends & Future Outlook of the Market?

Shift Towards Home-Based Care

Growing health awareness is increasing the adoption of home-based care solutions, which is driving the demand for outpatient & home infusion services. They are being preferred to offer decentralized and patient-centered care to enhance patient comfort, convenience, and outcomes.

Expanding Specialty Therapies

Increasing advancements in immunotherapies, biologics, and other infusion treatments are driving the demand for long-term outpatient & home infusion services. This increases their adoption rates for chronic disease management and diseases involving complex therapies.

Technological Advancements

Growing technological advancements are propelling the development of smart infusion pumps and remote monitoring systems. These advancements are driving the development of new platforms with enhanced safety, scalability, and real-time monitoring features.

Quick Facts Table

Segmental Insights

By Service Type Insights

The Home Infusion Therapy Segment Dominated the Market With 55% in 2025

The home infusion therapy segment led the outpatient & home infusion services market with 55% share in 2025, due to growth in the preference for home-based care. The growth in the demand for chronic disease management has also increased its adoption rates. The rise in technological advancements in infusion devices has also increased their use.

The outpatient infusion therapy segment held the second-largest share of 42% of the market in 2025, due to a shift towards outpatient services. These services also enhance patient convenience and reduce hospital stays, which promotes their use. The growing chronic disease burden also promotes their use.

The immunoglobulin therapy sub-segment held 10% of the outpatient & home infusion services market share in 2025 and is expected to witness the fastest growth with a CAGR of 12% during the forecast period, due to a surge in autoimmune disease therapies, innovative delivery methods reducing hospital visits. Their strong safety profile and efficiency are increasing their use. Their expanding applications are also increasing their demand.

By Disease Type Insights

The Cancer Segment Dominated the Market With 40% in 2025

The cancer segment accounted for the highest revenue share of 40% of the outpatient & home infusion services market in 2025, due to high cancer incidence rates. The rise in outpatient cancer care also increased the adoption of outpatient and home infusion services. The growth in the adoption of targeted therapies also encouraged their use.

The autoimmune diseases segment held the second-largest share of 28% of market share in 2025, due to the rise in autoimmune disorders and the biologics revolutionizing outpatient care. The growing need for long-term treatment options is also increasing their use. Increasing home-based treatment and infusion devices innovations are also increasing their use.

The infectious diseases segment held 16% of the market share in 2025, due to advancements in home infusion technology for managing complex infections. Increasing adoption of IV antibiotics is also increasing the adoption of the outpatient & home infusion services. Moreover, the reduced risk of hospital-acquired infection also increases their use.

The rheumatoid arthritis sub-segment held 10% of the outpatient & home infusion services market share in 2025 and is expected to show the highest growth with a CAGR of 12.50% during the forecast period, due to increasing biologic therapy usage. The growing patient preference for home care is also increasing the use of outpatient & home infusion services. Increasing awareness and autoimmune disorders are also increasing their use.

By Product Type Insights

The IV Infusion Sets Segment Dominated the Market With 30% in 2025

The IV infusion sets segment held a major revenue share of 30% of the outpatient & home infusion services market in 2025, due to consistent demand for high-quality, cost-effective infusion sets in home and outpatient settings. Their safety standards and ease of use also increased their use. Their disposable nature also contributed to their continuous use.

The infusion pumps segment held the second-largest share of 25% of the market in 2025, due to technological advancements in pump automation, reducing human error in drug delivery. This is driving their use in the treatment of chronic diseases. The growing development of smart pumps and the shift towards home-based care are also increasing their use.

The IV bags segment held 20% of the outpatient & home infusion services market share in 2025, due to the growing volume of home infusions. Their high sterility, disposability, and safety are also increasing their use. Their standardized dosing and portability are also increasing their demand.

The others segment held 10% of the market share in 2025 and is expected to expand rapidly with a CAGR of 9.10% during the forecast period, due to new products entering the market, such as smart infusion systems and devices integrating AI. The growing focus on infection prevention is also increasing their demand. A rise in the safety-enhanced devices is also increasing their use.

By End-User Insights

The Outpatient Centers Segment Dominated the Market in 2025

The outpatient centers segment contributed the biggest revenue share of the outpatient & home infusion services market in 2025, due to their affordable services and advanced technologies. Their shorter waiting times also attracted patients, which increased the use of outpatient & home infusion services. The presence of insurance policies also increased their use.

The homecare providers segment held the second-largest share of the market in 2025 and is expected to show the highest CAGR growth during the forecast period, due to a growing shift towards home-based care. Their affordability and growth in chronic disease burden also increased their use. The presence of portable devices and skilled professionals is also increasing their use.

The hospitals segment is expected to show significant growth in the outpatient & home infusion services market share in 2025, driven by high patient trust and the presence of skilled professionals. Advanced infrastructure and emergency support also drive their demand. Large patient volume and reimbursement policies also increase their use.

The specialty clinics segment is expected to show notable growth in the market share in 2025, due to their high-quality personalized care. Their focused expertise and strong referral networks are also increasing their use. Expanding standalone specialty care clinics are also increasing their use.

Regional Insights

High Healthcare Expenditure Drives North America

North America dominated the outpatient & home infusion services market with 47% in 2025, due to high healthcare expenditure, aging population, and strong home care infrastructure. The presence of favorable insurance and early adoption of infusion technologies also increased the use of outpatient & home infusion services. The growth in chronic disease also contributed to the market growth.

U.S. Market Trends

The U.S. is leading in home healthcare services, advanced healthcare facilities, and payer support for home therapies, which fuels the use of outpatient & home infusion services. The growing shift towards value-based care is also increasing their use. Technological advancements and growing chronic disease burden are also increasing their adoption rates.

Shift Towards Home Healthcare Services Boosts the Asia Pacific

Asia Pacific held 16% share of the outpatient & home infusion services market in 2025 and is expected to grow at the fastest CAGR of 9.50% during the forecast period, due to growing demand for home healthcare services, especially in emerging markets like China and India. Large patient population and expanding healthcare infrastructure are also increasing the use of outpatient & home infusion services. Growing medical tourism and government support are also enhancing the market growth.

China Market Trends

China held 6% market share in 2025 and is expected to show the fastest growth with 10.20% CAGR during the forecast period, due to the expansion of healthcare services and a growing elderly population. Growing patient volume, government initiatives, and new therapies are also expanding the use of outpatient & home infusion services. Expanding specialty clinics and health awareness are also promoting their use.

Market Value Chain Analysis

R&D

• The R&D of the outpatient & home infusion services focuses on the development of extended stability drug formulations, AI-driven smart pumps, and remote patient monitoring platforms.
• Key players: Baxter International, Fresenius Kabi.

Clinical Trials and Regulatory Approvals

• The safety, efficacy, affordability, stability, software reliability, and user interface errors are evaluated in the clinical trials and regulatory approvals of the outpatient & home infusion services.
• Key players: Patient Support and Services

Patient Support and Services

• Comprehensive education, personalized clinical monitoring, and 24/7 nursing support are provided in the patient support and services of the outpatient & home infusion services.
• Key players: Option Care Health, Optum, CVS Health.

Top Vendors and Their Offerings

SWOT Analysis

Strengths

• The outpatient & home infusion services offer affordable solutions that increase their adoption rates.
• They also enhance the patient's convenience and comfort, promoting adherence to the treatment.
• They also help in reducing the hospital burden and risk of hospital-acquired infections, which increases their use.
• Their shorter treatment time and patient-centric care also drive their adoption rates.

Weaknesses

• Limited emergency support acts as the major weakness in the outpatient & home infusion services market, reducing their acceptance rates.
• Dependence on skilled personnel and internet connectivity also reduces their use.

Opportunities

• Growing incidences of chronic diseases are increasing the demand for outpatient & home infusion services.
• Increasing shift towards value-based care is also driving their adoption rates.
• Expanding remote healthcare and collaborations are also promoting their innovations.
• Growing technological innovations and advanced drug products are also driving their advancements.

Threats

• High production costs associated with advanced facilities and processes limit their innovations.
• Stringent quality control and regulatory requirement also slow down their advancements.

What are the Recent Developments in the Market?

• In September 2025, the launch of Advanced Infusion Care Centers (AICC) and the opening of its first location in Phoenix, AZ, were announced by Advanced Infusion Care (AIC). This launch supports the strategic commitment of the company to offer outpatient infusion therapy with enhanced patient convenience, clinical excellence, and comfort through a dedicated state-of-the-art center.
• In August 2025, Terufusion Advanced Infusion Systems was launched by Terumo India. This system integrates Smart Infusion Pump (volumetric), Pump Monitoring System software, and Smart Syringe Pump to offer precise, transparent, and efficient drug delivery along with remote monitoring, integrated drug library, and customisable dose modes.

Segments Covered in the Report

By Service Type

• Home Infusion Therapy
  • Parenteral Nutrition
  • Antibiotic Therapy
  • Chemotherapy
  • Pain Management
  • Immunoglobulin Therapy
• Outpatient Infusion Therapy
  • Chemotherapy Infusion
  • Immunotherapy
  • Biologic Infusion
  • Pain Management
  • Hydration Therapy

By Disease Type

• Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others
• Autoimmune Diseases
  • Rheumatoid Arthritis
  • Crohn's Disease
  • Multiple Sclerosis
  • Psoriasis
• Infectious Diseases
  • Bacterial Infections
  • HIV/AIDS
  • Hepatitis
  • Tuberculosis
• Pain Management
  • Chronic Pain
  • Acute Pain
  • Neuropathic Pain
• Others
  • Cardiac Conditions
  • Endocrine Disorders
  • Neurological Diseases

By Product Type

• IV Infusion Sets
• Infusion Pumps
• IV Bags
• Catheters
• Others

By End-User

• Hospitals
• Homecare Providers
• Outpatient Centers
• Specialty Clinics

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA